Physician profile
Michelle E Akler
NPI 1639150899
$2,973.93
in general payments reported to CMS, 2019-2025
16 companies · $1,811 in 2025
The $1,811 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $114 · 2021: $205 · 2022: $296 · 2023: $243 · 2024: $198 · 2025: $1,811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,400 · Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,400.00 |
| Food and Beverage | $852.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,400.00 | 2025 | |
| Alcon Vision LLC | $781.97 | 2019-2025 | Clareon, Argos, Rocklatan |
| Genentech USA, INC. | $145.13 | 2022 | |
| Rxsight INC | $109.88 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Ivantis, INC | $105.21 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $87.94 | 2024-2025 | Xdemvy |
| Allergan, INC. | $82.93 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $59.66 | 2023-2024 | Xiidra, Miebo, Envista Mx60 Iol |
| Abbvie INC. | $49.97 | 2022 | |
| Boston Scientific Corporation | $39.28 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Sun Pharmaceutical Industries INC. | $24.64 | 2025 | |
| Oyster Point Pharma, INC. | $23.67 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.72 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $16.57 | 2023 | Tecnis Simplicity |
| Biotissue Holdings INC. | $15.01 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $9.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Akler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.